Trials start of mRNA vaccine for HIV

Volunteers in the US recently received the first experimental doses of a new type of HIV vaccine. Using Moderna’s mRNA platform, the vaccine has been developed in partnership with the International Aids Vaccine Initiative (IAVI). While huge amounts of development are still required to create a successful vaccine, the speed and flexibility of mRNA may accelerate the process.